Oct 22, 7:32 AM ET
Vita Coco reported third-quarter 2026 net sales of $244 million, up 34% from a year earlier, and net income of $35 million, or $0.58 per diluted share, compared with $24 million, or $0.40, a year earlier. The company raised its full-year 2026 net sales guidance to $810 million to $820 million and adjusted EBITDA guidance to $170 million to $175 million, with growth partly driven by the Copra acquisition completed in July 2026.
- Q3 2026 net sales of $244 million, up $62 million or 34%; organic net sales growth was 18%
- Q3 net income of $35 million ($0.58 per diluted share) versus $24 million ($0.40) a year earlier
- Full-year 2026 net sales guidance raised to $810 million to $820 million from $790 million to $805 million; adjusted EBITDA guidance raised to $170 million to $175 million from $154 million to $161 million
- Fourth-quarter gross margin is expected to be approximately 33%, and cash fell to $152 million at September 30, 2026 after the $139 million Copra payment
Read the filing on SEC.gov ↗
Jul 23, 7:20 AM ET
Vita Coco reported second-quarter 2026 net sales of $216 million, up 28%, and net income of $49 million, or $0.82 per diluted share, compared with $23 million, or $0.38 per diluted share, a year earlier. The company raised its full-year 2026 net sales and Adjusted EBITDA guidance, and the filing states that the outlook includes the Copra, Inc. acquisition completed on July 22, 2026.
- Second-quarter gross margin was 49% versus 36%, with tariff refunds providing a 700 basis point benefit to gross margin in the quarter.
- Full-year 2026 net sales guidance is $790 million to $805 million, up from $720 million to $735 million; Adjusted EBITDA guidance is $154 million to $161 million, up from $132 million to $138 million.
- On July 21, 2026, the Board approved an additional $40 million share repurchase authorization, bringing the total to $105 million.
- The Company acquired Copra, Inc., a producer of super-premium Thai Nam Hom coconut water, on July 22, 2026.
Read the filing on SEC.gov ↗
Jul 22, 4:38 PM ET
Vita Coco completed its acquisition of Copra, Inc. on July 22, 2026, with Copra becoming a wholly-owned subsidiary. Closing consideration was $175 million, paid partly in cash and partly in Vita Coco common stock, with up to $100 million more tied to Copra's 2028 results. The filing states that the acquisition does not materially affect Vita Coco's long-term Adjusted EBITDA margin target.
- Closed July 22, 2026; Copra survives as a wholly-owned subsidiary of Vita Coco.
- Closing consideration of $175 million: $140,000,210.59 in cash and 467,071 shares of Vita Coco common stock.
- Earnout of at least $45 million and at most $100 million, based on Copra's 2028 Gross Profit, payable in cash, stock or both at Vita Coco's discretion.
- Copra expects full-year 2026 Net Sales greater than $100 million; Vita Coco reports no change to its long-term financial targets.
Read the filing on SEC.gov ↗
Apr 29, 7:23 AM ET
Vita Coco reported first-quarter 2026 net sales of $180 million, up 37%, and net income of $30 million, up $12 million from a year earlier. The company raised its full-year 2026 net sales and adjusted EBITDA guidance, but the filing says the outlook could be affected by tariffs, geopolitical conditions and the military conflict in Iran.
- Net sales were $180 million, up from $131 million; Vita Coco Coconut Water net sales grew 42%.
- Net income was $30 million, or $0.50 per diluted share, compared with $0.31 a year earlier.
- 2026 net sales guidance was raised to $720 million to $735 million from $680 million to $700 million; adjusted EBITDA guidance was raised to $132 million to $138 million from $122 million to $128 million.
- The company repurchased $12 million of stock in the first quarter and had $21 million remaining under its $65 million repurchase program as of April 28, 2026.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.